Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-15-017827
Filing Date
2015-09-30
Accepted
2015-09-30 11:33:26
Documents
3
Period of Report
2015-11-10
Effectiveness Date
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A bota20150929_def14a.htm DEF 14A 650198
2 russsig.jpg GRAPHIC 2955
3 patti.jpg GRAPHIC 3961
  Complete submission text file 0001437749-15-017827.txt   661299
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 151133072
SIC: 2836 Biological Products, (No Diagnostic Substances)